Why Are So Few COPD Patients Getting Vital Rehab Treatment?
Title: Why Are So Few COPD Patients Getting Vital Rehab Treatment?Category: Health NewsCreated: 11/15/2018 12:00:00 AMLast Editorial Review: 11/15/2018 12:00:00 AM (Source: MedicineNet Lungs General)
Source: MedicineNet Lungs General - November 15, 2018 Category: Respiratory Medicine Source Type: news

Rural Americans More Likely to Die from Preventable Causes
Blog post from the National Conference of State Legislatures celebrating National Rural Health Day and drawing attention to rural health disparities. Although the country as a whole has seen declines in four of five leading causes of death, that decline is slower in rural areas. Rural people experience higher death rates from heart disease, cancer, unintentional injury, chronic lower respiratory disease, and stroke. (Source: News stories via the Rural Assistance Center)
Source: News stories via the Rural Assistance Center - November 15, 2018 Category: Rural Health Source Type: news

Researchers to study drivers of asthma in Puerto Rico
(National Jewish Health) Researchers at the University of California, San Francisco, National Jewish Health and Centro de Neumolog í a Pedi á trica in Puerto Rico have been awarded nearly $10 million in a 5-year grant to understand the root causes of asthma in Puerto Rico, where asthma prevalence and deaths are among the highest in the world. The team will follow 4,000 children from birth through early childhood to study how genes and viral infections affect respiratory disease. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 15, 2018 Category: International Medicine & Public Health Source Type: news

Glenmark Pharmaceuticals Announces New Data Presentations on Ryaltris at the ACAAI Annual Scientific Meeting 2018
MAHWAH, N.J., Nov. 15, 2018 /PRNewswire/ -- Glenmark Pharmaceuticals, a global pharmaceutical company, today announced that the company is presenting new data for for its leading respiratory pipeline candidate Ryaltris (rye - al' - tris)... (Source: Drugs.com - New Drug Applications)
Source: Drugs.com - New Drug Applications - November 15, 2018 Category: Drugs & Pharmacology Source Type: news

Protein assemblies ejected directly from native membranes yield complexes for mass spectrometry
Membrane proteins reside in lipid bilayers and are typically extracted from this environment for study, which often compromises their integrity. In this work, we ejected intact assemblies from membranes, without chemical disruption, and used mass spectrometry to define their composition. From Escherichia coli outer membranes, we identified a chaperone-porin association and lipid interactions in the β-barrel assembly machinery. We observed efflux pumps bridging inner and outer membranes, and from inner membranes we identified a pentameric pore of TonB, as well as the protein-conducting channel SecYEG in association wit...
Source: ScienceNOW - November 15, 2018 Category: Science Authors: Chorev, D. S., Baker, L. A., Wu, D., Beilsten-Edmands, V., Rouse, S. L., Zeev-Ben-Mordehai, T., Jiko, C., Samsudin, F., Gerle, C., Khalid, S., Stewart, A. G., Matthews, S. J., Grünewald, K., Robinson, C. V. Tags: Biochemistry reports Source Type: news

FDA Warns Against Off-Label Use of Implantable Pain Pumps
FDA is cautioning doctors and patients about the serious complications that can occur when using medications not approved for use with implanted pumps that deliver medication into the spinal fluid to treat or manage pain. Complications may include dosing errors, pump failure, opioid withdrawal, and infection, not to mention pain,  muscle spasms, cognitive changes, weakness, and cardiac or respiratory distress. “The treatment of pain has become increasingly complex. While medical devices, such as implanted pumps that deliver medication directly into the spinal fluid, have the potent...
Source: MDDI - November 14, 2018 Category: Medical Devices Authors: Amanda Pedersen Tags: Regulatory and Compliance Implants Source Type: news

Cochlear joins $17m round for sleep apnea nueromod dev Nyxoah
Cochlear Ltd. (ASX:COH) has joined a $17.1 million (EU €15 million) funding round for Nyxoah to support the development and commercialization of its hypoglossal nerve stim therapy for treating obstructive sleep apnea. Australian hearing tech developer Cochlear lead the round, investing $14.7 million (EU €13 million). The round was also joined by several existing Nyxoah shareholders, the Belgian company said. As part of the funding round, a member of Cochlear has joined Nyxoah’s board of directors. “Cochlear actively monitors the market for novel technologies and implantable devices that over the ...
Source: Mass Device - November 14, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Respiratory cochlear Nyxoah Source Type: news

ResMed closes $750m MatrixCare buy
ResMed (NYSE:RMD) said today that it closed the $750 million acquisition of MatrixCare and its post-acute-care software. The San Diego-based respiratory care giant said it funded the buyout, which represents a 25x EBITDA multiple, using its credit facility. Bloomington, Minn.-based MatrixCare put up sales of $122 million last year, ResMed said. “We’re all excited to have quickly closed this important deal and can officially welcome MatrixCare to the ResMed family,” ResMed CEO Mick Farrell said in prepared remarks. “ResMed is the world’s top tech-driven medical device c...
Source: Mass Device - November 14, 2018 Category: Medical Devices Authors: Brad Perriello Tags: Mergers & Acquisitions Respiratory Software / IT Wall Street Beat MatrixCare ResMed Inc. Source Type: news

Vapotherm prices $56m IPO
Vapotherm yesterday priced an initial public offering, aiming to raise $56 million for its respiratory device. Exeter, N.H.-based Vapotherm developed the Precision Flow line of devices to provide high-velocity heated, humidified and oxygenated air to treat patients with conditions such as pneumonia, chronic obstructive pulmonary disease, asthma and heart failure. Some 1,200 of the devices have been sold in the U.S., mostly into hospital ICUs, the company said. Vapotherm said it plans to issue 4 million shares at $14 apiece, hitting the low end of its prior range. The offering also includes a 30-day underwrit...
Source: Mass Device - November 14, 2018 Category: Medical Devices Authors: Brad Perriello Tags: Featured Funding Roundup Initial Public Offering (IPO) Respiratory Wall Street Beat Vapotherm Source Type: news

Africa: It's Time to Go Back to Basics in the Fight Against Childhood Pneumonia
[The Conversation Africa] Pneumonia is a respiratory infection that affects the lungs. The viruses and bacteria that cause the disease are spread through airborne droplets from a cough or sneeze. An infection can cause the lungs to fill with pus and fluid, making breathing and oxygen intake difficult. And while anyone can get pneumonia, children with weakened immune systems or underlying illnesses are more susceptible. That's why, pneumonia kills more than a million children every year across the world. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - November 14, 2018 Category: African Health Source Type: news

New virtual reconstruction of a Neanderthal thorax suggests another breathing mechanism
(University of the Basque Country) A research team, led by Dr Asier G ó mez-Olivencia, an Ikerbasque research fellow at the University of the Basque Country (UPV/EHU), and Dr Ella Been of the Ono Academic College of Tel Aviv, has carried out the first virtual reconstruction of the full fossil ribcage of the Neanderthal individual known as Kebara 2. The results show significant morphological differences pointing to a respiratory mechanism that was different in Neanderthals compared with that of modern humans. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - November 14, 2018 Category: Biology Source Type: news

More U.S. Kids Have Recently Been Diagnosed with a Mysterious Paralyzing Illness
(NEW YORK) — More children have been diagnosed with a mysterious paralyzing illness in recent weeks, and U.S. health officials said Tuesday that they still aren’t sure what’s causing it. This year’s count could surpass the tallies seen in similar outbreaks in 2014 and 2016, officials said. Fortunately, the disease remains rare: This year, there have been 90 cases spread among 27 states, the Centers for Disease Control and Prevention said. It’s not clear what’s causing some children to lose the ability to move their face, neck, back, arms or legs. The symptoms tend to occur about a week a...
Source: TIME: Health - November 13, 2018 Category: Consumer Health News Authors: MIKE STOBBE / AP Tags: Uncategorized onetime public health Source Type: news

AstraZeneca to divest US Synagis rights to Sobi
AstraZeneca has agreed to sell US rights to Synagis (palivizumab) used for the prevention of serious lower respiratory tract infection (LRTI) caused by respiratory syncytial virus (RSV) to Swedish Orphan Biovitrum AB (publ) (Sobi). Sobi will commercialise Synagis in the US and around 130 AstraZeneca employees will transfer to Sobi as part of the transaction. (Source: World Pharma News)
Source: World Pharma News - November 13, 2018 Category: Pharmaceuticals Tags: Featured AstraZeneca Business and Industry Source Type: news

Secondhand Smoke
Title: Secondhand SmokeCategory: Diseases and ConditionsCreated: 2/12/2010 12:00:00 AMLast Editorial Review: 11/13/2018 12:00:00 AM (Source: MedicineNet Lungs General)
Source: MedicineNet Lungs General - November 13, 2018 Category: Respiratory Medicine Source Type: news

Medical News Today: What to know about bradypnea (slow breathing)
Bradypnea is when a person is breathing at a slower rate than is usual for their age and activity level. Learn about bradypnea here, including its definition, causes, and treatment. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - November 12, 2018 Category: Consumer Health News Tags: Respiratory Source Type: news

Breaking the Smoking-Drinking Connection
Title: Breaking the Smoking-Drinking ConnectionCategory: Health NewsCreated: 11/12/2018 12:00:00 AMLast Editorial Review: 11/12/2018 12:00:00 AM (Source: MedicineNet Lungs General)
Source: MedicineNet Lungs General - November 12, 2018 Category: Respiratory Medicine Source Type: news

How pneumococci challenge our immune system
(Karolinska Institutet) Pneumococci are the most common cause of respiratory tract infections, such as otitis and sinusitis, as well as of severe infections like pneumonia and meningitis. A new study from Karolinska Institutet in Sweden published in Nature Microbiology shows how the bacteria can inhibit immune cell reaction and survive inside cells to give rise to pneumonia. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 12, 2018 Category: International Medicine & Public Health Source Type: news

A hub for respiratory care commissioning
The Primary Care Respiratory Academy Commissioning Platform aims to offer the tools and resources you need to optimise respiratory outcomes in your population. (Source: NHS Networks)
Source: NHS Networks - November 12, 2018 Category: UK Health Source Type: news

Physicians to NRA: This Is Our Lane Physicians to NRA: This Is Our Lane
Clinicians tweet their disgust at a National Rifle Association (NRA) report and tweet that attacked an ACP article aimed at reducing gun violence.Medscape Medical News (Source: Medscape Pulmonary Medicine Headlines)
Source: Medscape Pulmonary Medicine Headlines - November 9, 2018 Category: Respiratory Medicine Tags: Internal Medicine News Source Type: news

FDA to Ban Most Flavored E-Cigarettes
Title: FDA to Ban Most Flavored E-CigarettesCategory: Health NewsCreated: 11/9/2018 12:00:00 AMLast Editorial Review: 11/9/2018 12:00:00 AM (Source: MedicineNet Lungs General)
Source: MedicineNet Lungs General - November 9, 2018 Category: Respiratory Medicine Source Type: news

U.S. Smoking Rates Hit Record Low
Title: U.S. Smoking Rates Hit Record LowCategory: Health NewsCreated: 11/8/2018 12:00:00 AMLast Editorial Review: 11/9/2018 12:00:00 AM (Source: MedicineNet Lungs General)
Source: MedicineNet Lungs General - November 9, 2018 Category: Respiratory Medicine Source Type: news

Hypersensitivity Pneumonitis
Title: Hypersensitivity PneumonitisCategory: Diseases and ConditionsCreated: 12/31/1997 12:00:00 AMLast Editorial Review: 11/9/2018 12:00:00 AM (Source: MedicineNet Lungs General)
Source: MedicineNet Lungs General - November 9, 2018 Category: Respiratory Medicine Source Type: news

FDA Says Primatene Mist Inhaler is Back for Asthmatics
Title: FDA Says Primatene Mist Inhaler is Back for AsthmaticsCategory: Health NewsCreated: 11/8/2018 12:00:00 AMLast Editorial Review: 11/9/2018 12:00:00 AM (Source: MedicineNet Asthma General)
Source: MedicineNet Asthma General - November 9, 2018 Category: Respiratory Medicine Source Type: news

Can't shake a cold? Try these 10 techniques!
Some 70 percent of us will get a respiratory infection each year. It's the most common reason anyone goes to a doctor. There is little you can do to speed it up - but these 10 tips may help you, though. (Source: the Mail online | Health)
Source: the Mail online | Health - November 8, 2018 Category: Consumer Health News Source Type: news

14 Treated for Carbon Monoxide Exposure at Downtown Nashville Hotel
  NASHVILLE, Tenn. (WKRN) - Crews with the Nashville Fire Department were called to the Westin Nashville in downtown Wednesday morning for a carbon monoxide incident. The leak was reported around 6:45 a.m. at the hotel on Clark Place. At first, six people reported symptoms of CO exposure. The number of people feeling sick rose through the day. By 2 p.m., 14 people were treated by medics, including six who were taken to Vanderbilt University Medical Center. (Source: JEMS: Journal of Emergency Medical Services News)
Source: JEMS: Journal of Emergency Medical Services News - November 8, 2018 Category: Emergency Medicine Authors: WKRN Web Staff Tags: Airway & Respiratory News News Videos Source Type: news

14 Treated for Carbon Monoxide Exposure at Downtown Nashville Hotel
  NASHVILLE, Tenn. (WKRN) - Crews with the Nashville Fire Department were called to the Westin Nashville in downtown Wednesday morning for a carbon monoxide incident. The leak was reported around 6:45 a.m. at the hotel on Clark Place. At first, six people reported symptoms of CO exposure. The number of people feeling sick rose through the day. By 2 p.m., 14 people were treated by medics, including six who were taken to Vanderbilt University Medical Center. (Source: JEMS Patient Care)
Source: JEMS Patient Care - November 8, 2018 Category: Emergency Medicine Authors: WKRN Web Staff Tags: Airway & Respiratory News News Videos Source Type: news

Vaccination Strategy Can Prevent a Deadly Childhood Infection
The sound of pertussis, or whooping cough, is terrifying. It is the sound of someone coughing violently, and then gasping for air; the gasp is the “whoop” sound. Whooping cough is a highly contagious, potentially fatal respiratory disease, and a big problem in Texas. (Source: TMA News Room)
Source: TMA News Room - November 8, 2018 Category: Consumer Health News Source Type: news

FDA approves over-the-counter Primatene Mist inhaler
The FDA this week approved Amphastar Pharmaceuticals‘ (NSDQ:AMPH) over-the-counter Primatene Mist inhaler for the temporary relief of mild symptoms of intermittent asthma. The original version of Amphastar’s Primatene Mist device was taken off the market in 2011 because it contained chlorofluorocarbon propellants – a chemical compound that is linked to depletion of the Earth’s ozone layer. The company’s latest product contains hydrofluoroalkane propellants, which are permitted under current U.S. law. Get the full story at our sister site, Drug Delivery Business News. The post FDA approves...
Source: Mass Device - November 8, 2018 Category: Medical Devices Authors: Sarah Faulkner Tags: Drug-Device Combinations Featured Food & Drug Administration (FDA) Pharmaceuticals Respiratory Wall Street Beat Amphastar Pharmaceuticals Source Type: news

Nasal leptin injections may help cure breathing problems at night
Research, published in theAmerican Journal of Respiratory and Critical Care Medicine, suggests that nasal injections of leptin can alleviate upper airway obstruction, increasing ventilation, during sleep.MedicalXpress (Source: Society for Endocrinology)
Source: Society for Endocrinology - November 8, 2018 Category: Endocrinology Source Type: news

The Critical Role EMS Plays in Fighting the Flu
Influenza has been impacting public health on a global scale since the beginning of recorded history. Influenza, also known as the “flu,” has numerous organizations committed to public health research, developing vaccines, and educating on best practices to prepare for the upcoming flu season. By gaining an understanding of the flu through history, virology, and how it impacts our society, we can have a better appreciation for the commitment that’s involved with combating the flu. What Is Influenza (and What’s Not)? The eyes of an epidemiologist can twitch for a variety of reasons, one of them being...
Source: JEMS Special Topics - November 8, 2018 Category: Emergency Medicine Authors: Morgan K. Anderson, MPH Tags: Exclusive Articles Operations Source Type: news

The Critical Role EMS Plays in Fighting the Flu
Influenza has been impacting public health on a global scale since the beginning of recorded history. Influenza, also known as the “flu,” has numerous organizations committed to public health research, developing vaccines, and educating best practices preparing for the upcoming flu season. By gaining an understanding of the flu through history, virology, and how it impacts our society, we can have a better appreciation for the commitment that’s involved with combating the flu. What Is Influenza (and What’s Not)? The eyes of an epidemiologist can twitch for a variety of reasons, one of them being whe...
Source: JEMS Operations - November 8, 2018 Category: Emergency Medicine Authors: Morgan K. Anderson, MPH Tags: Exclusive Articles Operations Source Type: news

Your Showerhead May Be Bathing You in Germs
(Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - November 7, 2018 Category: Respiratory Medicine Tags: Infections, Pulmonology, News, Source Type: news

Medical News Today: Hyperventilation: Causes and what to do
Hyperventilation refers to fast breathing. The most common cause is fear or anxiety, but underlying medical conditions may also contribute to hyperventilation. Learn more here. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - November 7, 2018 Category: Consumer Health News Tags: Respiratory Source Type: news

Philips to shut down Respironics facility in Kennesaw, affecting hundreds
Philips Respironics makes sleep and respiratory products and services for managing sleep apnea, oxygen therapy, noninvasive ventilation and respiratory drug therapy. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - November 7, 2018 Category: Biotechnology Authors: Jessica Saunders Source Type: news

Philips to shut down Respironics facility in Kennesaw, affecting hundreds
Philips Respironics makes sleep and respiratory products and services for managing sleep apnea, oxygen therapy, noninvasive ventilation and respiratory drug therapy. (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - November 7, 2018 Category: American Health Authors: Jessica Saunders Source Type: news

Philips to shut down Respironics facility in Kennesaw, affecting hundreds
Philips Respironics makes sleep and respiratory products and services for managing sleep apnea, oxygen therapy, noninvasive ventilation and respiratory drug therapy. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - November 7, 2018 Category: Biotechnology Authors: Jessica Saunders Source Type: news

Philips to shut down Respironics facility in Kennesaw, affecting hundreds
Philips Respironics makes sleep and respiratory products and services for managing sleep apnea, oxygen therapy, noninvasive ventilation and respiratory drug therapy. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - November 7, 2018 Category: Pharmaceuticals Authors: Jessica Saunders Source Type: news

Color Atlas of Mycology
2018Post date: Wednesday, November 7, 2018 - 09:14Books and theses (Source: The Aspergillus Website - updates)
Source: The Aspergillus Website - updates - November 7, 2018 Category: Respiratory Medicine Authors: GAtherton Source Type: news

The Sooner You Quit Smoking, the Better
Title: The Sooner You Quit Smoking, the BetterCategory: Health NewsCreated: 11/6/2018 12:00:00 AMLast Editorial Review: 11/7/2018 12:00:00 AM (Source: MedicineNet Lungs General)
Source: MedicineNet Lungs General - November 7, 2018 Category: Respiratory Medicine Source Type: news

Raising the Intubation Bar is Noble, But Not Practical
We thank Mr. Wood and Mr. Podsialdo for their insightful comments regarding the Pragmatic Airway Resuscitation Trial (PART) results.  With regards to their comment of prior studies finding better outcomes with intubation than supraglottic airways, one must bear in mind that these prior studies were biased by their retrospective designs; the airway was selected by paramedic choice and may have been influenced by a range of factors such as the patient’s condition, anatomy, the physical environment or the practitioner’s level of comfort. Meta-analysis or systematic reviews of these retrospective studies ...
Source: JEMS Special Topics - November 6, 2018 Category: Emergency Medicine Authors: Shannon W. Stephens, EMT-P Tags: Airway & Respiratory Exclusive Articles Source Type: news

Raising the Intubation Bar is Noble, But Not Practical
We thank Mr. Wood and Mr. Podsialdo for their insightful comments regarding the Pragmatic Airway Resuscitation Trial (PART) results.  With regards to their comment of prior studies finding better outcomes with intubation than supraglottic airways, one must bear in mind that these prior studies were biased by their retrospective designs; the airway was selected by paramedic choice and may have been influenced by a range of factors such as the patient’s condition, anatomy, the physical environment or the practitioner’s level of comfort. Meta-analysis or systematic reviews of these retrospective studies ...
Source: JEMS Patient Care - November 6, 2018 Category: Emergency Medicine Authors: Shannon W. Stephens, EMT-P Tags: Airway & Respiratory Exclusive Articles Source Type: news

It ’s About Paramedic Intubation Skill Maintenance, Not ETI vs. SGA
Conclusion The PART study’s aim was to demonstrate that SGA is superior to SETI. Whether this is true or not remains to be seen. That doesn’t mean this study doesn’t have value. It clearly demonstrated that an important, time-honored and gold standard skill in resuscitation isn’t being practiced effectively by paramedics. The solution should not be to abandon the procedure. The solution is that we need to fix the problem. We need to enhance education, provide more opportunity for skills maintenance and develop systems that ensure that paramedics are regularly practicing these advanced skills. It is ...
Source: JEMS Special Topics - November 6, 2018 Category: Emergency Medicine Authors: Stephen P. Wood, MS, ACNP-BC Tags: Airway & Respiratory Exclusive Articles Source Type: news

It ’s About Paramedic Intubation Skill Maintenance, Not ETI vs. SGA
In this study, for all-comers, that was an abysmal 6%. This is an important number because it tells us that overall, successful resuscitation from cardiac arrest is rare and that a number of our efforts may have some statistically significant differences but the absolute effect on the gold standard outcome is rather small. But that’s a story for another time. The focus here is on airway management in cardiac arrest, and the suggestion that the “verdict is out” on whether or not paramedics should be using an endotracheal tube or a supraglottic device. (Source: JEMS Patient Care)
Source: JEMS Patient Care - November 6, 2018 Category: Emergency Medicine Authors: Stephen P. Wood, MS, ACNP-BC Tags: Airway & Respiratory Exclusive Articles Source Type: news

Endotracheal-Suctioning Curb Tied to Respiratory Problems in Some Newborns Endotracheal-Suctioning Curb Tied to Respiratory Problems in Some Newborns
Avoidance of routine endotracheal suctioning of meconium-stained nonvigorous newborns, as recommended in recent guidelines, may be associated with a higher risk of respiratory problems, according to Texas-based researchers.Reuters Health Information (Source: Medscape Critical Care Headlines)
Source: Medscape Critical Care Headlines - November 6, 2018 Category: Intensive Care Tags: Pediatrics News Source Type: news

AstraZeneca sells trio of respiratory drugs for $350m
(Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - November 6, 2018 Category: Pharmaceuticals Source Type: news

Hookah Pipes Far From Harmless, Study Warns
Title: Hookah Pipes Far From Harmless, Study WarnsCategory: Health NewsCreated: 11/5/2018 12:00:00 AMLast Editorial Review: 11/6/2018 12:00:00 AM (Source: MedicineNet Lungs General)
Source: MedicineNet Lungs General - November 6, 2018 Category: Respiratory Medicine Source Type: news

Medical News Today: What is empyema?
Empyema is when too much fluid collects in the pleural space in the lungs. Learn about the symptoms, stages, and possible causes here. We also cover treatment options. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - November 5, 2018 Category: Consumer Health News Tags: Respiratory Source Type: news

Gala Therapeutics launches RheOx chronic bronchitis trial
Gala Therapeutics said today that it launched an early feasibility study of its RheOx system for treating chronic bronchitis, and that the first two patients in the trial have already been enrolled. Initial patient enrollment took place at the University of Pittsburgh Medical Center, with RheOx bronchial rheoplasty procedures performed by Dr. Frank Sciurba and Roy Semaan, the Menlo Park, Calif.-based company said. “We are pleased to partner with Gala in treating the first US patients and thus continuing the contribution of UPMC as a leader in the development of novel devices for our patients with COPD. RheOx off...
Source: Mass Device - November 5, 2018 Category: Medical Devices Authors: Fink Densford Tags: Clinical Trials Respiratory galatherapeutics Source Type: news

ResMed to pay $750m for MatrixCare
ResMed (NYSE:RMD) said today that it agreed to pay $750 million to acquire MatrixCare and its post-acute-care software. The San Diego-based respiratory care giant said it plans to fund the buyout, which represents a 25x EBITDA multiple, using its credit facility. Bloomington, Minn.-based MatrixCare put up sales of $122 million last year, ResMed said. “The acquisition of MatrixCare is an excellent addition to the out-of-hospital software portfolio that we can offer our healthcare provider customers,” CEO Mick Farrell. “ResMed is the world’s leading tech-driven medical device compa...
Source: Mass Device - November 5, 2018 Category: Medical Devices Authors: Brad Perriello Tags: Featured Mergers & Acquisitions Respiratory Software / IT MatrixCare ResMed Inc. Source Type: news

Vapotherm sets range for $60m IPO
Vapotherm today set the pricing range on an initial public offering that would fetch $60 million at the midpoint. Exeter, N.H.-based Vapotherm developed the Precision Flow line of devices to provide high-velocity heated, humidified and oxygenated air to treat patients with conditions such as pneumonia, chronic obstructive pulmonary disease, asthma and heart failure. Some 1,200 of the devices have been sold in the U.S., mostly into hospital ICUs, the company said. Today Vapotherm said it plans to issue 4 million shares priced at $14 to $16 apiece, for gross proceeds of $56.0 million to $64 million. Vapotherm has said t...
Source: Mass Device - November 5, 2018 Category: Medical Devices Authors: Brad Perriello Tags: Featured Funding Roundup Initial Public Offering (IPO) Respiratory Wall Street Beat Source Type: news